EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Making sense of TILs : recommendations for morphological assessment of tumour‐infiltrating lymphocytes in colorectal carcinoma: a report on behalf of the International Immuno‐Oncology Biomarker Working Group

Daniel Sur, Corinna Lang‐Schwarz, Filip van Herpe, Gertjan Rasschaert, Ylva A Weeda, Nickolas Littlefield, Qiangqiang Gu, Nianyi Li, Hardas Alexandros, Akira I Hida, Amarpreet Bhalla, Andrey I Khramtsov, Anna Ehinger, Atsushi Tanaka, Balazs Acs, Sanna Steen, Caner Ercan, Cornelia M Focke, Daniel Ehinger, Dan Huang, Weiqi Sheng, Galina F Khramtsova, Haruto Nishida, Selim Sevim, Shin Ichihara, Shinnisuke Morikawa, Stefan Michiels, Thomas Papathomas, Toshihiro Haga, Hoel Kervadec, Hugo M Horlings, Francisco Sanchez‐Vega, Jelena Y Janjigian, Myriam Chalabi, Hanneke WM van Laarhoven, Liudmila L Kodach, Sybren L Meijer, David S Williams, Anthony J Gill, Sherene Loi

Histopathology · 2026-11-03

DOI: 10.1111/his.70307 ↗
AbstractBibliografische Angaben

Abstract

Tumour‐infiltrating lymphocytes (TILs) are recognized as critical components of the colorectal cancer (CRC) immune microenvironment, demonstrating significant prognostic and predictive implications. However, a clear and widely accepted definition of colorectal TILs has not yet been established, and TILs are not systematically used as biomarkers in current oncology practice. This highlights the need for standardized assessment methods and a deeper understanding of the complex role of TILs in CRC, necessitating collaborative work to achieve clinical importance. This report, on behalf of the International Immuno‐Oncology Biomarker Working Group (ITWG), provides a comprehensive overview of TILs in CRC, including a TILs‐assessment method. It details their multifaceted role of TILs within the tumour microenvironment, details current and emerging methods for their assessment and reviews their prognostic and predictive importance. The report also explores the relationship of TILs to other established and emerging biomarkers in CRC. Emerging trends, including AI‐driven analysis for automated TIL quantification, and single‐cell and spatial technologies for in‐depth characterization of the tumour microenvironment (TME), are also highlighted. The report concludes with a discussion of future directions and the ongoing efforts of the ITWG to address the challenges and standardize and advance the clinical application of TIL assessment in CRC.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →